♧
Evidence-Based Medical Source Standard
Every clinical parameter, threshold, and equation implemented on this
site is directly traceable to peer-reviewed medical publications,
landmark nephrology/endocrinology studies, or international clinical
consensus guidelines (such as the International Workshop on Primary
Hyperparathyroidism and NICE guidelines). We do not cite unverified
blogs or commercial SEO articles.
Primary Hyperparathyroidism (PHPT) evaluation & threshold guidelines
Evaluation and Management of Primary Hyperparathyroidism:
Summary Statement and Guidelines from the Fifth International Workshop
Bilezikian JP, Silverberg SJ, Bandeira F, et al.
(2022). Journal of Bone and Mineral Research, 37(11): 2293–2314.
Key Clinical Contribution:
Recommends 24-hour urinary calcium and calcium-creatinine
clearance ratio (CCCR) to differentiate PHPT from Familial
Hypocalciuric Hypercalcemia (FHH). Highlights overlap between
0.01 and 0.02 and the clinical necessity of vitamin D repletion
before interpretation.
Genetics, clinical presentation, and CCCR variability across FHH types
Familial Hypocalciuric Hypercalcaemia I–III:
clinical and laboratory findings in patients with CASR, GNA11,
and AP2S1 mutations
Christensen SE, Nissen PH, Vestergaard P, Heickendorff L,
Brixen K, Mosekilde L. (2010).
European Journal of Endocrinology, 162(4): 371–382.
Key Clinical Contribution:
Evaluates large cohorts of genetically verified FHH types 1, 2,
and 3. Demonstrates that while CCCR <0.01 has high specificity
for FHH, up to 20–35% of genetically proven FHH patients may
exhibit CCCR values in the indeterminate 0.01–0.02 range.
Clinical practice guidance for distinguishing PHPT and FHH
Hyperparathyroidism (primary): diagnosis, assessment and initial
management (NICE Guideline NG132)
National Institute for Health and Care Excellence (NICE) (2019).
NICE Clinical Guidelines, Guideline NG132.
Key Clinical Contribution:
Recommends measuring urinary calcium excretion and calculating the
calcium-to-creatinine clearance ratio prior to surgical
parathyroidectomy, warning against neck exploration in suspected
FHH where surgery is ineffective.
Pathophysiology of calcium sensing receptor (CaSR) and renal calcium handling
Hyperparathyroid and Hypoparathyroid Disorders
Marx SJ. (2000).
New England Journal of Medicine, 343(25): 1863–1875.
Key Clinical Contribution:
Seminal review describing calcium homeostasis, the renal
calcium-sensing receptor, and how loss-of-function CaSR variants
shift the renal setpoint upward, resulting in persistent
hypocalciuria despite systemic hypercalcemia.
Diagnostic overlap and limitations of CCCR cutoffs
The calcium–creatinine clearance ratio: is it reliable for
distinguishing primary hyperparathyroidism from familial
hypocalciuric hypercalcemia?
Shih MC Jr, Dahir KM. (2013).
World Journal of Surgery, 37(9): 2154–2158.
Key Clinical Contribution:
Demonstrated that up to 22% of surgically verified PHPT patients
had a CCCR <0.01 when evaluated before surgery, often compounded
by severe vitamin D deficiency or renal impairment, underscoring
that CCCR cannot be used as an infallible test.
Mathematical validation of paired urine and serum clearance ratios
The Calcium:Creatinine Clearance Ratio:
A Useful Diagnostic Index in Primary Hyperparathyroidism and
Familial Hypocalciuric Hypercalcaemia
Warner J, et al. (1993).
Annals of Clinical Biochemistry, 30(Pt 4): 374–378.
Key Clinical Contribution:
Establishes the physiological validity of calculating the
clearance ratio without timed volumetric 24-hour urine
collection error, confirming that urine flow rate cancels out
when paired clearances are concurrently measured.